Customizing solutions for RNA-based therapeutics

A growing biotech company researching early phase development of RNA-based therapies against cancer needed a CRO partner with a global footprint and decades of oncology expertise to help them navigate their next generation medicine from bench to market. As an emerging enterprise; flexibility and customizable solutions were critical for their program.

Filed In

Preclinical & Nonclinical